The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro

Author:

Stope, M. B.; Weiss, M.; Popp, S. L.; Joffroy, C.; Buck, M. B.; Mustea, A.; Brucker, S.; Wallwiener, D.; Knabbe, C.

Tübinger Autor(en):

Published in:

European Journal of Gynaecological Oncology (2019), Bd. 40, H. 1, S. 16-18

Verlagsangabe:

I R O G Canada

Language:

English

Full text:

ISSN:

0392-2936

DDC Classifikation:

610 - Medicine and health

Dokumentart:

Article

This item appears in the following Collection(s)